InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Pankovcin Corinne, Chief Financial Officer. Director active across 1 companies, notably Aditx Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Total volume traded: €18k. The latest transaction was disclosed on 4 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
055,000 shares0
Common Stock
SEC:0001213900-21-031445·
055,000 shares0
Common Stock
SEC:0001213900-21-031445:0·
€8,8204,220 shares@ €2.09100.0% of flow
Common Stock
SEC:0001213900-21-029170·
Ideal exit: 19 Feb 2022 (T+270)
€8,8204,220 shares@ €2.0950.0% of flow
Common Stock
SEC:0001213900-21-029170:0·
Ideal exit: 19 Feb 2022 (T+270)
4 of 4 declarations
About Pankovcin Corinne
Corinne Pankovcin is the Chief Financial Officer at Aditx Therapeutics, Inc. In this role, she oversees the company's financial operations, including budgeting and risk management. Her expertise is crucial for ensuring the company's financial health.
